NDC 69315-701

ETHACRYNATE SODIUM

Ethacrynate Sodium

ETHACRYNATE SODIUM is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Leading Pharma, Llc. The primary component is Ethacrynate Sodium.

Product ID69315-701_f07b4be7-32d2-4173-8a3a-75065b78079d
NDC69315-701
Product TypeHuman Prescription Drug
Proprietary NameETHACRYNATE SODIUM
Generic NameEthacrynate Sodium
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2020-10-15
Marketing CategoryANDA /
Application NumberANDA208663
Labeler NameLeading Pharma, LLC
Substance NameETHACRYNATE SODIUM
Active Ingredient Strength50 mg/50mL
Pharm ClassesIncreased Diuresis at Loop of Henle [PE],Loop Diuretic [EPC]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 69315-701-50

1 VIAL, SINGLE-DOSE in 1 CARTON (69315-701-50) > 50 mL in 1 VIAL, SINGLE-DOSE
Marketing Start Date2020-10-15
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "ETHACRYNATE SODIUM" or generic name "Ethacrynate Sodium"

NDCBrand NameGeneric Name
42023-157ETHACRYNATE SODIUMethacrynate sodium
68382-246Ethacrynate SodiumEthacrynate Sodium
69315-701ETHACRYNATE SODIUMETHACRYNATE SODIUM
70771-1106Ethacrynate SodiumEthacrynate Sodium
25010-210SODIUM EDECRINethacrynate sodium

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.